Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first1,141 to 1,160 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| ITGA6 integrin subunit alpha 6 | 3655 HGNC:6142 | 1 | 56 | 0 | 0 | 4,010 | 6,234 |
| GNAQ G protein subunit alpha q | 2776 HGNC:4390 | 1 | 66 | 0 | 0 | 3,829 | 6,231 |
| IL2RG interleukin 2 receptor subunit gamma | 3561 HGNC:6010 | 1 | 326 | 8 | 854 | 4,787 | 6,229 |
| ROCK1 Rho associated coiled-coil containing protein kinase 1 | 6093 HGNC:10251 | 1 | 58 | 14 | 87 | 2,986 | 6,226 |
| FLI1 Fli-1 proto-oncogene, ETS transcription factor | 2313 HGNC:3749 | 1 | 74 | 0 | 0 | 3,122 | 6,218 |
| VCP valosin containing protein | 7415 HGNC:12666 | 1 | 73 | 0 | 0 | 3,527 | 6,217 |
| KAT2B lysine acetyltransferase 2B | 8850 HGNC:8638 | 1 | 36 | 0 | 0 | 4,030 | 6,211 |
| FOXA2 forkhead box A2 | 3170 HGNC:5022 | 1 | 75 | 0 | 0 | 4,593 | 6,209 |
| HBEGF heparin binding EGF like growth factor | 1839 HGNC:3059 | 1 | 145 | 1 | 1 | 4,519 | 6,206 |
| SFTPA1 surfactant protein A1 | 653509 HGNC:10798 | 1 | 86 | 0 | 0 | 2,427 | 6,201 |
| FGF1 fibroblast growth factor 1 | 2246 HGNC:3665 | 1 | 412 | 6 | 45 | 3,223 | 6,200 |
| CDK9 cyclin dependent kinase 9 | 1025 HGNC:1780 | 1 | 44 | 11 | 87 | 3,784 | 6,198 |
| HSP90B2P heat shock protein 90 beta family member 2, pseudogene | 7190 HGNC:12099 | 1 | 0 | 0 | 0 | 2,789 | 6,195 |
| PDX1 pancreatic and duodenal homeobox 1 | 3651 HGNC:6107 | 1 | 91 | 0 | 0 | 3,957 | 6,194 |
| COG2 component of oligomeric golgi complex 2 | 22796 HGNC:6546 | 1 | 22 | 0 | 0 | 1,940 | 6,191 |
| ADRB1 adrenoceptor beta 1 | 153 HGNC:285 | 1 | 93 | 74 | 1,230 | 3,429 | 6,187 |
| GC GC vitamin D binding protein | 2638 HGNC:4187 | 1 | 69 | 0 | 0 | 2,468 | 6,187 |
| C4B complement C4B (Chido/Rodgers blood group) | 721 HGNC:1324 | 2 | 92 | 0 | 0 | 3,302 | 6,183 |
| MSTN myostatin | 2660 HGNC:4223 | 1 | 334 | 7 | 20 | 2,419 | 6,178 |
| GAD2 glutamate decarboxylase 2 | 2572 HGNC:4093 | 1 | 281 | 0 | 0 | 2,991 | 6,177 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=58
{
"data": {
"total": 193990,
"results": [
{
"id": "3655",
"title": "ITGA6: integrin subunit alpha 6",
"summary": "NCBI Gene 3655. 1 protein, 56 patents, 0 drugs, 0 trials, 4,010 NIH grants and 6,234 papers.",
"record": "/library/genes/3655",
"gene_id": 3655,
"symbol": "ITGA6",
"name": "integrin subunit alpha 6",
"hgnc_id": "HGNC:6142",
"counts": {
"proteins": 1,
"patents": 56,
"drugs": 0,
"trials": 0,
"grants": 4010,
"papers": 6234
}
},
{
"id": "2776",
"title": "GNAQ: G protein subunit alpha q",
"summary": "NCBI Gene 2776. 1 protein, 66 patents, 0 drugs, 0 trials, 3,829 NIH grants and 6,231 papers.",
"record": "/library/genes/2776",
"gene_id": 2776,
"symbol": "GNAQ",
"name": "G protein subunit alpha q",
"hgnc_id": "HGNC:4390",
"counts": {
"proteins": 1,
"patents": 66,
"drugs": 0,
"trials": 0,
"grants": 3829,
"papers": 6231
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=59",
"request_id": "IYx3-O1vNTGKs41I"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant